TCF4 and glioblastoma: In addition, we previously demonstrated that TCF4 may act as a transcriptional inhibitor of GBM cell differentiation, by counteracting the pro-neuronal stimuli exerted by a Wnt signaling-induced HIF-1α/β-catenin complex activation, through TCF1 [9].